Breast Cancer Coordinated Care 3 (BC3) 2022

Breast cancer is the most common cancer affecting women. Diagnosis and treatments are part of the practice of a wide number of medical specialists and there are national initiatives calling for a multidisciplinary approach to the care of breast cancer patients. The multiple components and aspects of the treatment of breast cancer require a high level of coordinated care among different specialties. This coordination becomes even more challenging because of the rapid evolution of new treatment modalities and is especially important due to of the possibility of improved outcomes both in terms of curing the disease, as well as maintaining the physical and psychological well-being of the patient. We will offer presentations and panel discussions on a number of currently important topics on the 360 view of treatment in breast cancer, including integrative approaches to treatment, targeted chemotherapy, and de-escalation of surgical management. Speakers will seek to discuss financial toxicity in breast cancer. Surgical topics include oncoplastic surgery, the role of prophylactic mastectomy, technical pearls for nipple sparing mastectomy, re-innervation / nerve sparing mastectomies, lymphatic surgery, and state of the art reconstruction. We will examine nipple-sparing mastectomy both therapeutic and prophylactic, treatment of breast cancer in a previously augmented breast, the status of MRI screening for breast cancer, the effects of reconstruction on the delivery of post-mastectomy radiation, and the evolving role of alloplastic materials in breast reconstruction. It will also cover in depth the state-of-the-art emerging field of lymphatic surgery to treat lymphedema as well as sensory concerns to the most complex reconstructions available covering topics such as sensation sparing mastectomies to restoring sensation with nerve transfers. Experts in the field will cover the state of partial breast irradiation, intraoperative radiation therapy, timing and indications for post-mastectomy radiation, and chemotherapy and its role in restaging breast cancer.

1. Identify how artificial intelligence may impact breast cancer care in the future.
2. Recognize the impact that financial toxicity related to the care of breast cancer can have on access to care and on outcomes.
3. Implement integrative approaches to management of side effects.
4. Recognize the impact of breast cancer on the young patient.
5. Identify new frontiers of targeted chemotherapy.
6. Discuss strategies to de-escalate surgical approaches.
7. Apply an evidence-based protocol for the conservative treatment of lymphedema, including primary, adjunctive, and alternative treatments.
8. Identify the new options available to surgically treat patients with lymphedema.
9. Describe different philosophies regarding radiation delivery including new techniques and how to minimize side effects to the surrounding tissue.
10. Implement surgical techniques designed to improve the likelihood of nipple preservation and reduce the risk of flap or nipple necrosis with mastectomy.
11. Define the roles and responsibilities of physical and occupational therapists in the continuum of care post-mastectomy.
12. Describe different philosophies regarding timing of radiation, radiation delivery and reconstruction and how to minimize side effects.
13. Identify the different methods of breast reconstruction including implant-based reconstruction, flap-based reconstruction, and microsurgical-assisted free flap reconstruction.
14. Identify the importance of the total care of the patient including the financial burden and impact this may have on the healing process.
15. Recognize racial disparities in breast cancer treatment.
16. Identify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with breast cancer.
17. Integrate a team-based approach in the care of patients with breast cancer.

Advance Registration
NOW to September 14 (closes at 12PM)

Physician $899
Resident or Fellow $319
Physician Assistant $619
Nurse Practitioner $619
Nurse $619
Allied Health Professional $619
Physical Therapist or Occupational Therapist $619
Industry Professional $1,000

On-Site Registration
September 15 to 17, 2022

Physician $999
Resident or Fellow $369
Physician Assistant $919
Nurse Practitioner $919
Nurse $919
Allied Health Professional $919
Physical Therapist or Occupational Therapist $919
Industry Professional $1,000

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.



Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 13.75 Interprofessional Continuing Education (IPCE) credits for learning and change.





Physicians: MedStar Health designates this live activity for a maximum of 13.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses: This activity is approved for 13.75 ANCC contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Occupational Therapists: An application has been made to the Maryland Board of Occupational Therapy Practice for continuing education credits.

Physical Therapists: An application has been made to the Maryland Board of Physical Therapy Examiners for continuing education credits. 

Renaissance Washington DC Downtown (changing to The Westin)
Address: 999 9th St NW, Washington, DC 20001
Phone: (202) 898-9000

Reserve by August 24, 2022!

Reservations: https://book.passkey.com/go/bc3conference 

Mitigation of Relevant Financial Relationships

MedStar Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.

Individuals in a position to control the content of this CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed below have been mitigated prior to the commencement of the activity.

Faculty Member Information

Role in activity

Name of Ineligible Company(s) / Nature of Relationship(s)

Kenneth L. Fan, MD
Scientific Director, Plastic & Reconstructive Surgery, Attending, Plastic Surgeon, Assistant Professor, 4th Year Clerkship Director
MedStar Health Research Institute, MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, D.C.

Activity Co-Director Content Reviewer, Faculty

Nothing to disclose

Lucy De La Cruz, MD
Chief, Breast Surgery, Director, Ourisman Breast Center Director
MedStar Georgetown University Hospital
Washington, DC

Activity Co-Director, Faculty

Speakers Bureau-Medtronic, Inc.

Ian T. Greenwalt, MD
Attending Surgeon, Breast Surgical Oncology, Assistant Professor, General Surgery
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, DC

Activity Co-Director, Faculty

Honoraria-Kubtec (Relationship has ended)

David H. Song, MD, MBA, FACS
Physician Executive Director, Integrated Surgical Services
MedStar Health
Washington, D.C.

Course Director, Faculty

Nothing to disclose

Nadia Ashai, MD
Breast Medical Oncologist
Georgetown Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital
Washington, DC

Faculty

Nothing to disclose

Marc E. Boisvert, MD, FACS
Chief, Washington Regional Breast Surgery, Medical Director, Center for Breast Health, Program Director, Breast Oncology Fellowship, Professor, Surgery
MedStar Health, MedStar Washington Hospital Center, MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, D.C.

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Mammatome

Wei F. Chen, MD, FACS
Co-Director, Center for Lymphedema Research and Reconstruction, Surgeon, Plastic and Reconstructive Surgery, Head, Microsurgery & Supermicrosurgery, Professor, Surgery
Cleveland Clinic, Case Western Reserve University School of Medicine
Cleveland, OH

Faculty

Nothing to disclose

Patricia Clark, MD, FACS
Breast and Oncoplastic Surgeon
The Ironwood Women’s Centers , Ironwood Cancer and Research Centers
Scottsdale, AZ

Faculty

Honoraria-Medtronic, Inc.|Honoraria-Hologic, Inc.

Brian J. Czerniecki, MD, PhD
Chair and Senior Member, Department of Breast Oncology, Program Leader in Breast Oncology
Mason Chair in Oncology, Moffitt Cancer Center
Tampa, FL

Faculty

Nothing to disclose

Gabriel Del Corral, MD, FACS
Director, MedStar Center for Gender Affirmation, Plastic & Reconstructive Surgery, Associate Professor, Plastic Surgery
MedStar Franklin Square Medical Center, MedStar Washington Hospital Center, Georgetown University School of Medicine
Baltimore, MD

Faculty

Nothing to disclose

Warren A. Ellsworth IV, MD, FACS
Medical Director, Plastic Surgery, Associate Professor, Plastic Surgery, Adjunct Associate Professor, Plastic Surgery
Houston Methodist West Hospital, Weill Cornell Medical College, Baylor College of Medicine
Houston, TX

Faculty

Consulting Fee-AbbVie|Speakers Bureau-Sientra (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Melodi|Consulting Fee-Axogen (Relationship has ended)

Ramon Go, MD
Medical Director, Acute Pain Service, Assistant Professor, Anesthesiology
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, DC

Faculty

Nothing to disclose

Sharad Goyal, MD
Chief, Radiation Oncology, Professor, Radiology
The George Washington University
Washington, DC

Faculty

Nothing to disclose

Kathleen Kiernan Harnden, MD, MBA
Director, Breast Medical Oncology, Assistant Professor, Medicine
Inova Schar Cancer Institute, University of Virginia
Fairfax, VA

Faculty

Advisor-Pfizer, Inc.|Speakers Bureau-SeaGen|Speakers Bureau-Eisai (Relationship has ended)|Speakers Bureau-Astra Zeneca Astra Zeneca|Speakers Bureau-Daiichi Sankyo, Inc.

Claudine Isaacs, MD
Associate Director, Clinical Research, Co-Director, Fisher Center for Hereditary Cancer and Clinical Genomics Research, Professor, Medicine and Oncology, Leader, Clinical Breast Cancer Program
Georgetown University, MedStar Georgetown University Hospital
Washington, D.C.

Faculty

Royalties or Patent Beneficiary-Wolters Kluwer|Royalties or Patent Beneficiary-Elsevier|Consulting Fee-SeaGen|Consulting Fee-PUMA|Consulting Fee-Novartis Pharmaceuticals|Consulting Fee-Biotheranostics (Relationship has ended)|Consulting Fee-Immunomedics (Relationship has ended)|Consulting Fee-Sanofi (Relationship has ended)|Honoraria-PER (Physician Education Resources)|Consulting Fee-Pfizer, Inc.|Honoraria-OncLive|Honoraria-Taylor Francis|Honoraria-IntrinsiqAmerisourcebergen (Relationship has ended)|Honoraria-ION|Consulting Fee-Clinical Advances Hematology Oncology Monograph (Relationship has ended)|Other: Medical Director/Advisor Not For Profit-SideOut|Other: Grant Reviewer -BCRF (Breast Cancer Research Foundation) (Relationship has ended)

Daniel R. Leff, FRCS, MS, PhD
Reader in Breast Surgery, Honorary Consultant Oncoplastic Breast Surgeon, Department of Surgery and Cancer
BioSurgery and Surgical Technology, Imperial College London
London, England

Faculty

Nothing to disclose

Candace Mainor, MD
Breast Medical Oncologist, Assistant Professor, Medicine, Division Hematology and Oncology
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, DC

Faculty

Nothing to disclose

Bruce Mann, MBBS, PhD
Surgical Oncologist, Director, Breast Cancer Services, Professor, Surgery
Royal Melbourne and Royal Women’s Hospital, The University of Melbourne
KEW, Australia

Faculty

Grant or research support-PreludeDx

Evan Matros, MD, MMSc, MPH
Associate Attending, Plastic Surgery
Memorial Sloan Kettering Cancer Center
New York, NY

Faculty

Nothing to disclose

Ketan M. Patel, MD
Associate Professor, Plastic Surgery
University of Southern California
Los Angeles, CA

Faculty

Nothing to disclose

Anne W. Peled, MD
Plastic and Reconstructive Surgery, Breast Surgery
Sutter Health California Pacific Medical Center
San Francisco, CA

Faculty

Consulting Fee-Axogen|Consulting Fee-Mammotome|Consulting Fee-Stryker Corporation|Consulting Fee-Sientra|Consulting Fee-Allergan

Ziv M. Peled, MD
Plastic and Peripheral Nerve Surgeon
Peled Plastic Surgery
San Francisco, CA

Faculty

Consulting Fee-Axogen

Katherine W. Power, MD
Program Director, Cancer Rehabilitation Fellowship, Clinical Assistant Professor, Rehabilitation Medicine
MedStar National Rehabilitation Network, Georgetown University School of Medicine
Washington, D.C.

Faculty

Nothing to disclose

Sonali Rudra, MD
Director, Breast Cancer Radiation Oncology Program, Assistant Professor, Radiation Medicine
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, D.C.

Faculty

Nothing to disclose

Hani Sbitany, MD, FACS
Chief, Plastic and Reconstructive Surgery, Associate Professor, Surgery
Mount Sinai West Medical Center, Mount Sinai Medical Center
New York, NY

Faculty

Consulting Fee-AbbVie

Deana Shenaq, MD
Director, Microsurgery, Co-Director, Breast Cancer Service Line, Program Director, Plastic Surgery Residency & Fellowship, Assistant Professor, Division of Plastic & Reconstructive Surgery
Rush University Medical Center
Chicago, IL

Faculty

Nothing to disclose

Karen L. Smith, MD, MPH
Medical Oncologist, Breast Cancer, Assistant Professor, Oncology
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Women’s Malignancies Disease Group, Johns Hopkins University School of Medicine
Baltimore, MD

Faculty

Grant or research support-Pfizer, Inc.|Stocks or stock options, excluding diversified mutual funds-Abbott|Stocks or stock options, excluding diversified mutual funds-AbbVie

Jennifer D. Son, MD
Director, Breast Health Center, Assistant Professor of Surgery
MedStar Montgomery Medical Center, MedStar Georgetown School of Medicine
Washington, DC

Faculty

Nothing to disclose

Judy H. Song, MD
Chief, Breast Imaging Department of Radiology, Assistant Professor, Radiology
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, D.C.

Faculty

Nothing to disclose

Peter J. Taub, MD, MS, FACS, FAAP
Professor of Surgery, Pediatrics, Dentistry, and Neurosurgery
The Mount Sinai Hospital
New York, NY

Faculty

Nothing to disclose

Neil K. Taunk, MD, MSCTS
Radiation Oncologist, Director, Imaging Sciences Research, Assistant Professor, Radiation Oncology and Radiology
Penn Medicine Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA

Faculty

Consulting Fee-Boston Scientific Boston Scientific Boston Scientific

Laura K. Tom, MD
Attending Physician, Plastic and Reconstructive Surgery
MedStar Washington Hospital Center
Washington, D.C.

Faculty

Nothing to disclose

Robert D. Warren, MD, MBA, FACP
Clinical Professor, Medicine
MedStar Georgetown University Hospital
Washington, DC

Faculty

Patricia Wehner, MD, FACS
Surgeon, Breast, Associate Program Director, MedStar Georgetown Breast Fellowship, Site Director, Breast Surgery, Assistant Professor, Surgery
MedStar Regional Breast Health Program, MedStar Southern Maryland Hospital, MedStar Washington Hospital Center, MedStar Georgetown University Hospital, MedStar Southern Maryland Hospital, Georgetown University School of Medicine
Washington, DC

Faculty

Nothing to disclose

Anna C. Weiss, MD
Surgeon, Breast Surgery, Assistant Professor, Surgery
Dana-Farber/Brigham Cancer Center, Harvard Medical School
Boston, MA

Faculty

Grant or research support-Myriad Laboratories, Inc

Shawna C. Willey, MD, FACS
Peterson Chair of Breast Cancer Research, Program Director, Breast Oncology Fellowship, Professor, Medical Education
Inova Schar Cancer Institute, Inova Fairfax Hospital, University of Virginia, Inova Campus
FairFax, VA

Faculty

Speakers Bureau-Hologic, Inc.|Speakers Bureau-Medtronic, Inc.

Eric Wisotzky, MD
Chief, Division of Rehabilitation Medicine; Director, Cancer Rehabilitation; Associate Professor, Rehabilitation Medicine
MedStar National Rehabilitation Network, Georgetown University School of Medicine
Washington, DC

Faculty

Nothing to disclose

Jay C. Zeck, MD
Medical Director, Laboratory Medicine; Associate Professor, Pathology
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, DC

Faculty

Nothing to disclose

Allison Hayes, NP
Nurse Practitioner
MedStar Georgetown University Hospital
Washington, D.C.

Faculty, Planning Committee Member

Nothing to disclose

Maureen McBeth, MPT, CLT-LANA
Physical Therapist
M. McBeth Consulting, LLC
Ellicott City, MD

Faculty, Planning Committee Member

Employment-Impedimed

Please contact Elizabeth Romano at [email protected] for information on exhibiting at this conference.

Thank you to our confirmed exhibitors!

Platinum
3M Healthcare

Bronze
ARSA

Exhibitors
Allergan 
Axogen
Endomag
Exact Sciences
Hologic
Kubtec
MedStar Rehabilitation 
Mitaka 
Paxman USA
Pfizer
PreludeDx
Seagen
Tactile Medical
Vioptix 

Your health and safety are MedStar Health, Inc.’s top priority, and we are taking the necessary precautions to make ensure this year’s events are safe as we continue to face the challenges of COVID-19.

Breast Cancer Coordinated Care (BC3) is committed to providing a welcoming and safe learning environment while cautiously planning for a live conference. We will continue to monitor federal, state and local recommendations and will update these protocols and measures as appropriate.

We reserve the right to modify these policies and procedures at any time given the rapidly changing nature of the current global pandemic.

General safety and wellness measures include but are not limited to:

• Hand sanitizing stations throughout public areas
• Cleaning between sessions
• Signage posted with reminders for physical distancing and hand washing

COVID-19 vaccination is required for attendance. In cases where an attendee or exhibitor has a valid medical or religious exemption, a negative PCR COVID-19 test within 72 hours of arrival to the convention center will be required.

Please check back for updates on how to input your COVID vaccination or exemption status prior to the conference.

Venue
As part of our Connect with Confidence initiatives, Marriott strongly encourages our associates to be vaccinated for COVID 19.  Through Marriott’s Vaccination Care Program, a financial award is provided to US hotel associates at managed properties who get vaccinated.  However, vaccination is not mandatory and information on vaccination status is shared by our associates on a voluntary basis.

For more information about to expect at the Renaissance Washington DC Downtown Hotel please visit https://whattoexpect.marriott.com/wasrb

COVID-19 Assumption of Risk, Waiver and Compliance Commitment
I am aware of the inherent risk of exposure to the COVID-19 virus involved in attending the in-person Breast Cancer Coordinated Care (BC3) conference and that COVID-19 is a highly contagious disease that can lead to sever illness and death. I voluntarily assume all risks related to exposure to COVID-19 when attending MedStar Health, Inc. related conferences and waive liability against MedStar Health, Inc., it’s associates, directors, contractors and staff for any loss, damages, or suffering relating to exposure to COVID-19.

Daily Self Health Screening
BC3 recommends that all participants screen themselves daily for symptoms. Symptoms may appear 2 – 14 days after exposure to the virus. The following symptoms are outlined on the CDC Website indicating an individual may have COVID-19:

• Fever or chills
• Cough
• Shortness of breath or difficulty breathing
• Fatigue
• Muscle or body aches
• Headache
• New loss of taste or smell
• Sore throat
• Congestion or runny nose
• Nausea or vomiting
• Diarrhea

Individuals who have these symptoms and are unwell should not attend the BC3 Conference. Additionally, if the person is onsite, affected individuals should notify event organizers to allow for additional communication to participants. 

Additional Resources

·         Centers for Disease Control and Prevention

·         World Health Organization

We thank you for your continued support and look forward to welcoming you to Breast Cancer Coordinated Care (BC3) conference in September. We have a stellar line up of speakers and agenda topics to advance your education, and exhibitors to showcase their latest products.